Generally, the role of the MMR gene–protein system is well known in LS, on one hand, and it has become a value tool in the oncologic field to address a potential aggressive profile of a tumor and its suitability for ICPI, on the other hand. This evidence concerns the gene MRC1 and neoplasm.